Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565994 · ClinicalTrials.gov registry record
A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 60
- Enrollment target
NCT00565994: Completed study, sponsored by University of Oklahoma.
NCT00565994 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00565994 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
We hope to study components within the blood that may predict success, failure or other associated complications in relation to the type of vascular access being used.
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-09 |
What the finished NCT00565994 record still lists
NCT00565994 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT00565994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00565994 about?
NCT00565994 is a clinical study titled "A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure". We hope to study components within the blood that may predict success, failure or other associated complications in relation to the type of vascular access being used.
What is the current status of trial NCT00565994?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-01. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00565994?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT00565994?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia